Lord Abbett Health Care I holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Lord Abbett Health Care Fund Class I LHCIX
- NAV / 1-Day Return 21.80 / +1.82 %
- Total Assets 7.9M
-
Adj. Expense Ratio
0.780%
- Expense Ratio 0.780%
- Distribution Fee Level Below Average
- Share Class Type Institutional
- Category Health
- Investment Style Mid Growth
- Min. Initial Investment 1M
- Status Open
- TTM Yield 0.37%
- Turnover 91%
USD | NAV as of Jun 10, 2026 | 1-Day Return as of Jun 10, 2026, 12:30 AM GMT+0
Morningstar’s Analysis LHCIX
Will LHCIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the LHCIX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of LHCIX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 38.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 9.06 | 724,315 | Healthcare |
AstraZeneca PLC | 4.82 | 385,099 | Healthcare |
Gilead Sciences Inc | 4.33 | 346,333 | Healthcare |
Johnson & Johnson | 3.25 | 259,501 | Healthcare |
Nektar Therapeutics | 3.23 | 258,352 | Healthcare |
Natera Inc | 2.97 | 237,290 | Healthcare |
Tarsus Pharmaceuticals Inc Ordinary Shares | 2.88 | 230,395 | Healthcare |
Guardant Health Inc | 2.68 | 214,130 | Healthcare |
argenx SE | 2.61 | 208,544 | Healthcare |
Novartis AG Registered Shares | 2.52 | 201,140 | Healthcare |
United States